COLLINS, HELEN L.,HNATYSZYN, JAMES,XIANG, HONG,ZHANG, XIANG
申请号：
CA3062177
公开号：
CA3062177A1
申请日:
2018.05.15
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
This application relates to uses of antibodies against fibroblastgrowth factor receptor 2 (FGFR2), including antibodies against the FGFR2isoform FGFR2-IIIb (also known as FGFR2b), in treatment of certain cancers incombinations with mFOLFOX6 chemotherapy.
